biospecimen banks

WRNMMC UsToo! Newsletter

 

Current Newsletter - MAY 2016, Volume 25 Issue1

After eleven years of the WRNMMC Prostate Cancer Newsletter distributed in hard copy via the US Postal Service, the newsletter is now completely "digital," and posted exclusively to the CPDR web site.

The WRNMMC US TOO Newsletter started as an eight page publication intended for the military prostate cancer community in the Greater Washington, D.C. metropolitan area. It grew rapidly under the leadership of the late Bob Zveare, the founding editor. Initially printed in 200 copies for local distribution, it is now digitally distributed far beyond "the Beltway."

The Newsletter is produced and distributed quarterly without charge to the expanded readership. Corporate grants and individual donations from the readership provide the financial wherewithal to sustain the operation. There are no paid employees. Instead, the Newsletter relies on volunteer effort from within the WRNMMC US TOO board of directors for its operation. The respective staffs of the WRNMMC Urology Service and the Department of Defense Center for Prostate Disease Research (CPDR) also provide support and encouragement.

 

Newsletter Archive

Index of Past Issues

February 2015, Volume 25 Issue 1

November 2015, Volume 24 Issue 4

August 2015, Volume 24 Issue 3

May 2015, Volume 24 Issue 2

February 2015, Volume 24 Issue 1

November 2014, Volume 23 Issue 4

August 2014, Volume 23 Issue 3

May 2014, Volume 23 Issue 2

February 2014, Volume 23 Issue 1

November 2013, Volume 22 Issue 4

August 2013, Volume 22 Issue 3

May 2013, Volume 22 Issue 2

February 2013, Volume 22 Issue 1

November 2012, Volume 21 Issue 4

August 2012, Volume 21 Issue 3

May 2012, Volume 21 Issue 2

February 2012, Volume 21 Issue 1

November 2011, Volume 20 Issue 3

August 2011, Volume 20 Issue 2

May 2011, Volume 20 Issue 1

August 2010, Volume 19 Issue 2

February 2010, Volume 19 Issue 1

November 2009, Volume 18 Issue 4<br>

August 2009, Volume 18 Issue 3

May 2009, Volume 18 Issue 2

February 2009, Volume 18 Issue 1

November 2008, Volume 17 Issue 4

August 2008, Volume 17 Issue 3

May 2008, Volume 17 Issue 2

February 2008, Volume 17 Issue 1

November 2007, Volume 16 Issue 4

August 2007, Volume 16 Issue 3

May 2007, Volume 16 Issue 2

February 2007, Volume 16 Issue 1

November 2006, Volume 15 Issue 4

August 2006, Volume 15 Issue 3

May 2006, Volume 15 Issue 2

February 2006, Volume 15 Issue 1

November 2005, Volume 14 Issue 4

August 2005, Volume 14 Issue 3

May 2005, Volume 14 Issue 2

February 2005, Volume 14 Issue 1

November 2004, Volume 13 Issue 4

August 2004, Volume 13 Issue 3

May 2004, Volume 13 Issue 2

February 2004, Volume 13 Issue 1

November 2003, Volume 12 Issue 4

August 2003, Volume 12 Issue 3

 

 

CURRENT EVENTS


WRNMMC UsToo!
Quarterly Guest Speakers


Tschlitz

Dr. Philip Arlen
National Cancer Institute

Topic: "Prostate Cancer: An Overview and Update of Novel Treatment Modalities"
There have been remarkable advances in the therapy for prostate cancer over the past decade. We will be discussing these advances as well as new treatment options in clinical trials.

Date: Thursday 5 May 2016
Time: 1900-2030
Location: Walter Reed National Military Medical Center (America Building, 2nd floor, Room 2525) and Fort Belvoir Community Hospital (via video teleconference in Oaks Pavilion, 1st floor, Room 332).

Read the MAY 2016 WRNMMC UsToo! Newsletter

Go to WRNMMC UsToo! Newsletter Archive

 

February 2, 2016

CPDR Urology Residents Take Top Awards at 2016 James C. Kimbrough Urological Seminar

Urology Residents conducting research at The Center for Prostate Disease Research (CPDR), Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center presented their research at the Residents Competition category of the James C. Kimbrough Urological Seminar, San Diego, 2016.

Read Full Article

 

January 11, 2016

A Novel Gene Alteration Associates with Aggressive Prostate Cancer in African American Men

The USU, Walter Reed-Bethesda and JPC collaborative team, through comprehensive evaluations of matched cohorts of African American and Caucasian American prostate cancers, previously established a higher frequency of ERG alterations in Caucasians (50-70%) and its significantly lower frequency in African Americans (20-25%). These intriguing observations actually provided the rational for the current study focusing on whole genome evaluations of prostate cancers from these two patient populations.

Read Full Article